Real-World Treatment Patterns, Healthcare Resource Utilization, Costs, and Survival Among Medicare Beneficiaries with Diffuse Large B-Cell Lymphoma (DLBCL)

被引：1
|
作者：
Garg, Mahek [1 ]
Huntington, Scott F. [2 ]
Puckett, Justin [3 ]
Kamal-Bahl, Sachin [4 ]
Raut, Monika [1 ]
Ryland, Katherine Elizabeth [5 ]
Doshi, Jalpa [6 ]
机构：
[1] Merck & Co Inc, Ctr Observat & Real World Evidence, Rahway, NJ USA
[2] Yale Univ, Dept Internal Med, Sect Hematol, Sch Med, New Haven, CT USA
[3] COVIA Hlth Solut, Philadelphia, PA USA
[4] COVIA Hlth Solut, Lansdale, PA USA
[5] Merck & Co Inc, Kenilworth, NJ USA
[6] Univ Penn, Perelman Sch Med, Div Gen Internal Med, Philadelphia, PA USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-158026
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10814 / 10815
页数：2
相关论文
共 50 条
  • [31] TREATMENT PATTERNS AMONG PATIENTS WITH RELAPSED/REFRACTORY (RIR) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) WHO ARE INELIGIBLE FOR TRANSPLANTATION - A REAL-WORLD STUDY USING FRENCH PMSI
    Di Blasi, R.
    Thieblemont, C.
    Haioun, C.
    Mayaud, A. C.
    Sala, Sackmann L.
    Diez-Andreu, P.
    Bugnard, F.
    Goguillot, M.
    Chillotti, L.
    Finzi, J.
    Benard, S.
    VALUE IN HEALTH, 2022, 25 (12) : S218 - S218
  • [32] Survival Patients Newly Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) - Real World Evidence from Germany
    Borchmann, Peter
    Papadimitrious, Michael
    Riou, Sybille
    Mahlich, Joerg
    Werner, Barbara
    BLOOD, 2022, 140 : 7919 - 7919
  • [33] Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy
    Sineshaw, Helmneh M.
    Zettler, Christina M.
    Prescott, Jennifer
    Garg, Mahek
    Chakraborty, Samhita
    Sarpong, Eric M.
    Bai, Claire
    Belli, Andrew J.
    Fernandes, Laura L.
    Wang, Ching-Kun
    CANCER MEDICINE, 2024, 13 (07):
  • [34] IDENTIFYING TREATMENT PATTERNS FOR DIFFUSE LARGE B-CELL LYMPHOMA IN REAL-WORLD DATA USING UNSUPERVISED MACHINE LEARNING
    Wang, Y.
    Vanness, D.
    VALUE IN HEALTH, 2023, 26 (06) : S287 - S287
  • [35] Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era
    Nair, Reena
    Bhat, Gull Mohammad
    Agrawal, Narendra
    Sengar, Manju
    Malhotra, Pankaj
    Nityanand, Soniya
    Lele, Chitra
    Reddy, Pramod
    Kankanwadi, Suresh
    Maharaj, Narendra
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [36] Evaluation of treatment patterns and survival among patients with diffuse large B-cell lymphoma in the USA
    Morrison, Vicki A.
    Shou, Yaping
    Bell, Jill A.
    Hamilton, Laurie
    Ogbonnaya, Augustina
    Raju, Aditya
    Hennenfent, Kristin
    Eaddy, Michael
    Galaznik, Aaron
    FUTURE ONCOLOGY, 2019, 15 (09) : 1021 - 1034
  • [37] Real-world practice patterns and outcomes in Veterans with relapsed/refractory diffuse large B-cell lymphoma
    Chien, Hsu-Chih
    Morreall, Deborah
    Patil, Vikas
    Rasmussen, Kelli M.
    Li, Chungyang
    Yong, Christina M.
    Burningham, Zachary
    Masaquel, Anthony
    Halloran, Mary
    De Long-Sieg, Elisha
    Schulz, Mathias
    Sauer, Brian C.
    Halwani, Ahmad S.
    FUTURE ONCOLOGY, 2020, 17 (04) : 411 - 422
  • [38] Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US database
    Studer, Sean
    Hull, Michael
    Pruett, Janis
    Koep, Eleena
    Tsang, Yuen
    Drake, William, III
    PULMONARY CIRCULATION, 2018, 9 (01)
  • [39] Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
    Griffiths, Robert
    Gleeson, Michelle
    Knopf, Kevin
    Danese, Mark
    BMC CANCER, 2010, 10
  • [40] Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
    Robert Griffiths
    Michelle Gleeson
    Kevin Knopf
    Mark Danese
    BMC Cancer, 10
12345